Oceania 20 Nov 2026 · Dr Natalya Mathur

4% more hepatitis b cases in Australia: 458 in the last 30 days

ENCLAI SURVEILLANCE BRIEFING · 20 NOVEMBER 20264% more hepatitis b cases in Australia:458 in the last 30 daysHepatitis B · Australia · reported cases458reported cases in the 30 days to 20 November▲ 4% more than the 30 days before (442)442The 30 daysbefore427Same 30 days, ayear earlier1,12190 days to 20November4,6882026 so farThree 30-day windows427A year earlier44230 days before458Last 30 daysLargest counts, last 90 daysThe US4,186Germany1,325Australia1,121Lithuania73Puerto Rico54South Korea5011 countries with a reported count in this windowWhat this briefing shows1Reported cases rose from 442 to 458 between the two latest 30-daywindows, 4% more.2The latest count of 458 is above the 427 reported in the same 30days a year earlier.3Australia accounts for 1.2% of the hepatitis b cases reported toENCLAI worldwide in 2026 and ranks 4 of 22 reporting countries.Read with care: reports to official surveillance, not people and not a rate. A change between30-day windows can come from reporting timing as much as from transmission.Source: official surveillance reports compiled by ENCLAI · data as of 2026-11-20 ·enclai.net/newsVerify every figure against the source data before use; ENCLAI does not guarantee accuracy orcompleteness.
  1. Reported cases rose from 442 to 458 between the two latest 30-day windows, 4% more.
  2. The latest count of 458 is above the 427 reported in the same 30 days a year earlier.
  3. Australia accounts for 1.2% of the hepatitis b cases reported to ENCLAI worldwide in 2026 and ranks 4 of 22 reporting countries.
Customise it in Visual Studio
Largest included reported counts (6 of 11 countries) · 2026-08-23 through 2026-11-20 · source-record dates; coverage varies
United States4,186
Germany1,325
Australia1,121
Lithuania73
Puerto Rico54
South Korea50
Hepatitis B — Australia · reported surveillance count · 2026-08-23 through 2026-11-20 · inclusive source-record dates
Hepatitis B — Australia · reported surveillance count · 2026-10-22 through 2026-11-20 · inclusive source-record dates
Hepatitis B — Australia · reported surveillance count · 2026-09-22 through 2026-10-21 · inclusive source-record dates
Hepatitis B — Australia · reported surveillance count · 2025-10-22 through 2025-11-20 · inclusive source-record dates
Hepatitis B · combined reported surveillance count · 2026-08-23 through 2026-11-20 · inclusive source-record dates
Hepatitis B · weekly reported-count series · Weeks starting 2026-08-17 through 2026-11-02
Largest included reported counts (6 of 11 countries) · 2026-08-23 through 2026-11-20 · source-record dates; coverage varies

The full briefing

Full 2026 picture: Hepatitis B in Australia — reported cases by year, monthly records and every briefing for this pair.

Australia reported 1,121 hepatitis b cases in the 90 days to 20 November. 458 of them came in the 30 days to 20 November, against 442 in the 30 days before. The same 30 days a year earlier had 427.

Why it matters

Australia accounts for 1.2% of the hepatitis b cases reported to ENCLAI worldwide so far in 2026. It ranks 4 of 22 reporting countries. 2025 closed at 5,379 cases, 2323% above the three-year baseline of 222 a year. 2026 so far stands at 4,688.

The numbers

PeriodReported cases
Last 30 days (to 20 November)458
The 30 days before that442
Same 30 days a year earlier427
90 days to 20 November1,121
2026 so far (ENCLAI export)4,688
Three-year baseline (a year)222
The card shows hepatitis b in Australia. It compares the last 30 days with the 30 days before, as reported to ENCLAI.
The card shows hepatitis b in Australia. It compares the last 30 days with the 30 days before, as reported to ENCLAI.

What the source says

These figures come from official surveillance reports. They count reports, not people. They are not an incidence rate, the rate of new cases in a population. They do not cover the whole population. The reporting periods do not match these dates exactly. Some reports are incomplete or still in progress. Some run past the window. Some reports do not say which date they use: symptom onset, notification, or confirmation.

Caveats

  • A change between two 30-day windows can come from reporting timing as much as from transmission. The source does not say which.

Where to learn more

Hepatitis B in Australia: the 2026 picture · Hepatitis B worldwide · Australia: all diseases · How to read these counts

Retained reporting context

Included reporting countries

Hepatitis B

6,951

combined reported surveillance count

2026-08-23 through 2026-11-20 · inclusive source-record dates

For Hepatitis B, the combined reported surveillance count across the 11 countries with positive reported counts in this selection is 6,951. The selection uses source-record dates 2026-08-23 through 2026-11-20, inclusive. This covers only these reporting countries; source periods and completeness vary.

Exact included country membership
CountryReported countSource-record dates
Australia1,1212026-08-23 through 2026-11-20
Germany1,3252026-08-23 through 2026-11-20
Spain442026-08-23 through 2026-11-20
Finland492026-08-23 through 2026-11-20
Guam82026-08-23 through 2026-11-20
Hungary42026-08-23 through 2026-11-20
South Korea502026-08-23 through 2026-11-20
Lithuania732026-08-23 through 2026-11-20
Latvia372026-08-23 through 2026-11-20
Puerto Rico542026-08-23 through 2026-11-20
United States4,1862026-08-23 through 2026-11-20

Snapshot 2026-11-20

Weekly reporting history

Hepatitis B

weekly reported-count series

Weeks starting 2026-08-17 through 2026-11-02

A retained retrospective weekly reported-count series across included reporting countries. Country membership and reporting completeness can vary by week. Missing weeks remain gaps. This is a separate report-series measure; it does not establish exact incidence or laboratory confirmation.

Retained weekly report series
WeekReported count
2026-08-17 through 2026-08-231202
2026-08-24 through 2026-08-301294
2026-08-31 through 2026-09-06789
2026-09-07 through 2026-09-131261
2026-09-14 through 2026-09-201013
2026-09-21 through 2026-09-27985
2026-09-28 through 2026-10-041179
2026-10-05 through 2026-10-11969
2026-10-12 through 2026-10-18954
2026-10-19 through 2026-10-25955
2026-10-26 through 2026-11-01959
2026-11-02 through 2026-11-081283

Snapshot 2026-11-20

Sources and limitations

  • Window. Each quantity keeps its recorded source-selection dates and coverage notes. Dated batches and weekly or genomic observations retain their separate measures. Publication or capture dates do not establish case onset, equal cohorts or period completeness.
  • Denominator. The retained counts do not establish complete populations, equal reporting cohorts or incidence rates. Source period bounds and definitions can differ.
  • Case definition. Case definitions are set nationally and change over time. Counts for the same disease in different countries may not be counting the same thing.
  • Revisions. Agencies restate figures. Values here are as reported at the time of publication; see the update history below.

ENCLAI counts reflect verified records available from reporting sources for the stated window. They are not estimates of total incidence and should not be interpreted as medical advice. Full methodology: the dataset.

Review and corrections

Share this briefing
ENCLAI tracks outbreaks like this live, from official sources worldwide. Start 7-day free trial  ·  Request a demo →

Follow ENCLAI News

Get new briefings in your news reader. No ENCLAI account needed.

The daily disease brief

One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.

Double opt-in — we send a confirmation link and nothing else until you click it. One-click unsubscribe on every email. See our privacy notice.